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Objective: To investigate the relation between breastfeeding, use of docosahexaenoic 
acid (DHA)-fortified formula and neuropsychological function in children. 
Design:  Prospective cohort study. 
Setting:  Southampton, UK. 
Subjects: 241 children aged 4 years followed up from birth. 
Main outcome measures:   IQ measured by the Wechsler Pre-School and Primary 
Scale of Intelligence (3rd edition), visual attention, visuomotor precision, sentence 
repetition and verbal fluency measured by the NEPSY, and visual form-constancy 
measured by the Test of Visual-Perceptual Skills (Non-Motor).  
Results:  In unadjusted analyses, children for whom breast milk or DHA-fortified 
formula was the main method of feeding throughout the first 6 months of life had 
higher mean full-scale and verbal IQ scores at age 4 years than those fed mainly 
unfortified formula. After adjustment for potential confounding factors, particularly 
maternal IQ and educational attainment, the differences in IQ between children in the 
breastmilk and unfortified formula groups were severely attenuated, but children who 
were fed DHA-fortified formula had full-scale and verbal IQ scores that were 
respectively 5.62 (0.98, 10.2) and 7.02 (1.56, 12.4) points higher than children fed 
unfortified formula.    However, estimated total intake of DHA in milk up to age 6 
months was not associated with subsequent IQ or with score on any other test. 
Conclusions:   Differences in children’s intelligence according to type of milk fed in 
infancy may be due more to confounding by maternal or family characteristics than to 
the amount of long-chain polyunsaturated fatty acids they receive in milk. 
 
Keywords:  breastfeeding, infant formula, long-chain polyunsaturated fatty acids, 
infancy, intelligence, neuropsychology
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Introduction 
 
There has been considerable interest in the role that long-chain polyunsaturated fatty 
acids (LCPUFAs) might play in neurodevelopment.   LCPUFAs, particularly the n-3 
docosahexaenoic acid (DHA) and the n-6 arachidonic acid (AA), are found in high 
concentrations in the brain and retina,1,2 and accumulate during the spurt in brain 
growth that occurs between the last trimester of pregnancy and the first year of life.3,4    
LCPUFAs, especially DHA, are involved in cell signalling, regulation of gene 
expression and neuronal growth. 5-7 Animal studies suggest that reductions in DHA 
accrual may lead to neurocognitive deficits.7,8 
  
Much of the evidence for the importance of LCPUFAs has come from observational 
studies comparing cognition in children who were breast-fed with those fed an infant 
milk formula or those breast-fed for different durations.    Most studies have found 
that breastfeeding is associated with better cognition, but few adjusted for the 
confounding effect of maternal intelligence. 9  Intelligence is heritable10 and women 
of higher intelligence are more likely to initiate breastfeeding and continue it for 
longer. 11   
 
Randomized controlled trials into the effects of LCPUFA-supplemented formula on 
cognitive or visual function have produced inconsistent findings. 8,12-14 Most trials 
have been carried out in babies or very young children.  Whether such formulas are 
associated with longer-term benefits in neurocognitive performance is unclear. 
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We investigated the relation between breastfeeding, use of LCPUFA-fortified formula 
in infancy and neuropsychological function in four-year-old children, controlling for 
the influence of maternal intelligence and other potential confounding factors. 
 
 
Methods 
 
The Southampton Women's Survey 
The Southampton Women's Survey (SWS) is a study of a population sample of non-
pregnant women aged 20 to 34 years, in Southampton, UK. Details of recruitment to 
the study and the representativeness of the sample have been described in detail 
previously.15 In brief, between 1998 and 2002 all general practitioners in 
Southampton were asked to help us recruit their female patients aged 20-34 years to 
the study.  The study was publicized locally and we recruited women not registered 
with GPs or who were registered with an incorrect address by approaching women at 
local events and in supermarkets in the city. Of those women contacted about the 
study, 12 583 (75%) agreed to participate.  The initial study and follow-ups were 
approved by Southampton and South West Hampshire Local Research Ethics 
Committee. Women gave written informed consent. 
 
Dietary assessment 
Children born to SWS women were followed-up at 6 months when a milk feeding 
history since birth was recorded.  Mothers reported type of milk feeding (including 
brand of formula) and duration. At the time we carried out our study there were 12 
infant formulas on the market that contained added DHA, with concentrations ranging 
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from 6.8 to 18mg/100ml of formula. For each baby we calculated the total number of 
days to age 6 months that he/she was fed breastmilk, DHA-fortified formula or 
unfortified formula.    We used k-means cluster analysis16 to identify groups that were 
homogeneous in the length of time they had received each type of milk.  This 
produced 3 clusters.   
 
To obtain an estimate of DHA exposure up to 6 months, we used average milk 
volumes 17 for each month of feeding together with the DHA content of the formula 
milk fed (obtained from the manufacturers); we assumed breast milk contained 9.56 
mg of DHA per 100g, based on a recent estimate of the DHA content of breast milk in 
the UK. 18  
 
Neuropsychological  assessment 
At age 4 years, children’s IQ was assessed at home using the Wechsler Pre-School 
and Primary Scale of Intelligence (3rd edition; WPPSI-III UK).19  We assessed 
attention, sensorimotor ability, memory and language using the subtests visual 
attention, visuomotor precision, sentence repetition and verbal fluency from the 
Developmental Neuropsychological Assessment (NEPSY). 20  We assessed visual 
perception abilities separate from motor skills using the visual form-constancy subtest 
of the Test of Visual-Perceptual Skills (Non-Motor).21   
  
Maternal and child characteristics 
Details of mother’s age, number of children, educational attainment, receipt of means-
tested benefits, and her and her partner’s current occupation were obtained at the pre-
pregnant interview.    Occupational social class was defined according to the highest 
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social class of the mother or her partner.22  At birth, the child was weighed using 
digital scales.  During the 4-year visit, maternal intelligence was assessed with the 
Wechsler Abbreviated Scale of Intelligence.23   The quality of the child’s environment 
was assessed using the short form of the Home Observation for Measurement of the 
Environment scale (HOME-SF). 24    
 
Participants  
There were 1981 singleton live births to women in the SWS up to the end of 2003.  
After exclusion of infants with major congenital abnormalities and neonatal deaths, 
1973 infants were available for follow-up.   Of these, 1645 (83%) were visited at 6 
months and 1618 (82%) at 12 months for dietary assessment.   Children with complete 
dietary data were invited to participate in studies at 4 years to assess bone mass, body 
composition and cognitive function.  For the cognitive function study, we aimed to 
recruit around 400 children. Power calculations – using observations from a previous 
study that the mean (SD) IQ of breastfed children were 104 (13) and that of formula 
fed children were 99 (15) - suggested that this would give us >90% power to detect a 
5-point difference in IQ between milk-feeding groups in infancy.    As children 
reached their 4th birthday, their mothers were invited to bring them for a DXA scan at 
the Southampton Osteoporosis Centre.  During this visit they were given an 
information sheet about the cognitive function study. Psychologists from the research 
team subsequently contacted the mothers by phone and invited them to take part in the 
study. During the three years for which the study was funded, 396 mothers were 
contacted. Of these, 268 (68%) participated.  Analyses are based on 241 children with 
complete data.   
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Compared to the rest of the SWS cohort with children born in 1999-2003 who did not 
take part in this study, the mothers who participated tended to have a higher level of 
educational attainment (p=0.05), were of higher social class (p=0.01) and had 
breastfed their baby for longer (p<0.001).   
 
Statistical analysis 
 
We used t-tests, the Mann-Whitney test, analysis of variance, 2 tests and correlation 
coefficients to examine characteristics.  We used linear regression to examine 
differences in scores in the breastfeeding and fortified-formula feeding groups 
compared to the unfortified-formula group, and differences in test scores according to 
total estimated dose of DHA up to age 6 months.   
 
 
 
Results 
 
There were 130 children in the breastmilk group (53.9%), 65 in the fortified-formula 
group (27%) and 46 in the unfortified-formula group (19.1%). Up to age 6 months, 
the breastmilk group had been fed breastmilk for a mean (SD) of 143.4 (30.4) days, 
the fortified-formula group had been fed fortified formula for 146.5 (34.4) days, and 
the unfortified-formula group had been fed unfortified formula for 147.3 (30.0) days.   
Mean (SD) total estimated DHA intake from milk between birth and age 6 months in 
the 3 groups was, respectively, 12.1 (1.88), 13.0 (5.6) and 2.14 (1.98) grams 
(p<0.001). 
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Table 1 shows characteristics according to feeding group.  The proportions of mothers 
with A levels or a degree or from social classes I or II were highest in the breastmilk 
group and lowest in the unfortified-formula group.  Mean IQ and mean age at birth 
were highest in the breastmilk group, lowest in the unfortified-formula group, and 
intermediate in the fortified-formula group.  Mothers in the breastmilk group were 
less likely to have received means-tested benefits than those in the formula groups.   
There were no differences between the groups in scores on the HOME cognitive 
stimulation or emotional support scales.  There was a gradient in birthweight across 
feeding groups, but sex, birth order or gestational age was not associated with feeding 
group.   Only characteristics that were significantly associated with infant feeding 
group were used as potential confounding factors in subsequent analyses. 
 
Table 2 shows regression coefficients for differences in IQ between children in the 
breastmilk or fortified-formula groups compared to those in the unfortified-formula 
group.  In unadjusted analysis, full-scale and verbal IQ scores were higher in children 
in the breastmilk and fortified-formula groups compared to those in the unfortified 
formula group.    There were no differences in performance IQ.    Adjustment for 
maternal education or intelligence attenuated the differences in full-scale and verbal 
IQ between the breastfed and the unfortified-formula groups such that they ceased to 
be statistically significant.  Control for potential confounding factors had less effect 
on the differences in full-scale and verbal IQ scores between children in the fortified- 
and unfortified formula groups.  Adjustment for maternal education or intelligence 
diminished the differences slightly, while adjustment for social class and other 
covariates had little or no attenuating effect.   In fully adjusted models, while the 
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differences in full-scale and verbal IQ scores between the breastfed and unfortified-
formula groups were not significant, the differences between the fortified- and 
unfortified-formula groups persisted. 
 
Table 3 shows differences in the other test scores between children in the breastmilk 
or fortified-formula groups compared to those in the unfortified-formula group.  There 
were no statistically significant differences in scores on any of these tests.   
 
Total estimated DHA intake in milk up to age 6 months ranged from 0 to 23.8 grams.  
Mothers of children with higher DHA intakes tended to have a higher IQ (r=0.28, 
p<0.001), be better educated (rs=0.28, p<0.001) and of higher social class (rs=-0.16, 
p=0.013).      Table 4 shows change in test score for a one-gram increase in total DHA 
intake.  In unadjusted analyses, there were weak positive associations between 
estimated total DHA intake and scores for visual form constancy and visual attention 
that remained of borderline significance when adjusted for potential confounders, but 
in general there were no indications to link increasing total DHA intake with better 
test performance.      We repeated these analyses restricting the sample to children in 
the two formula-fed groups.  In unadjusted analyses there was a weak positive 
association between DHA intake and verbal IQ, such that verbal IQ rose by 0.37 (95% 
CI 0.02, 0.73) of a point for a 1-gram increase in DHA intake, but after controlling for 
maternal IQ or educational attainment, this ceased to be statistically significant and it 
was attenuated further by additional adjustment for other potential confounders.  
There were no associations in the formula-fed groups between DHA intake and scores 
for full-scale or performance IQ or any other test. 
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Discussion 
 
Several trials have investigated the effect of LCPUFA-fortified formula on 
neurodevelopment.  In 276 term-born children followed up at 39 months, no 
differences were found in IQ, visual-motor skills or visual acuity between children 
randomised to LCPUFA-fortified formula in infancy, those randomised to unfortified 
formula and a breastfed comparison group.25    A trial of 79 term-born children found 
lower verbal IQ at age 4 years in children randomised to DHA-fortified or unfortified 
formula in infancy compared to a breastfed reference group, but there was no 
adjustment for potential confounding factors associated with the decision to 
breastfeed, and no evidence of a difference in IQ between the fortified and unfortified 
formula groups. 26  Term-born babies randomised to a LCPUFA-fortified formula 
showed a reduced occurrence of abnormal movements at 3 months in comparison to 
those receiving a control formula in a trial of 472 infants, 27 but there was no evidence 
of improved neurodevelopment at 18 months according to scores on Bayley Scales. 28  
In 238 pre-term infants, LCPUFA-fortified formula was associated with higher scores 
on the Mental Development Index of the Bayley Scales at 18 months, but only in 
boys; overall there were no differences in neurodevelopment between the formula 
groups. 29 In a similar trial in 179 pre-term infants, LCPUFA-fortified formula was 
linked with significantly higher Bayley Scales scores at 18 months. 30   One trial 
examined the effect of supplementing breastfeeding women with DHA and found that 
the children of supplemented women scored significantly higher than those of a 
control group on the Psychomotor Development Index of the Bayley Scales at age 30 
months, though there was no difference in score on the Mental Development Index.31 
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In this study, where neurodevelopment was assessed at a later age than in most of the 
above trials, we found a difference in mean full-scale and verbal IQ between children 
who had been fed fortified or unfortified formula that persisted after adjustment.  
Viewed in isolation, this might suggest that the LCPUFA content of fortified formula 
had benefited these children’s cognitive development. However, the lack of any trend 
between estimated total intake of DHA up to age 6 months and subsequent IQ makes 
this unlikely.  While this might reflect inaccuracies in our estimation of DHA intake, 
our results suggest that the apparent IQ advantage associated with fortified formula 
may be due less to the LCPUFA content of these milks, than to unmeasured factors in 
the home environment that influence the choice of fortified versus unfortified 
formula.    The fact that fortified formula was linked with differences in verbal but not 
performance IQ provides further support for this explanation.   
 
Although many observational studies have found that children who were breastfed 
gain higher scores on tests of intelligence, our findings suggest that this association is 
largely due to confounding.  Adjustment for maternal education or intelligence 
severely attenuated the association; no other covariate had such an effect.  These 
results are consistent with findings in the children of members of the National Survey 
of Health and Development, where adjustment for maternal cognition or education 
removed the positive association between IQ and being breastfed. 32 Similarly, in the 
US National Longitudinal Survey of Youth, breastfeeding had little or no effect on 
intelligence compared to bottle feeding after controlling for maternal IQ.33    Longer 
duration of breastfeeding has been linked with higher intelligence in the offspring in 
many studies. 34,35 Our finding that total intake of DHA in milk up to age 6 months 
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was not linked with subsequent intelligence provides a further indication that the 
association between breastmilk and cognitive development may not be due to the 
LCPUFA content of the milk.  
 
Evidence suggesting a role for breastfeeding in cognitive development has recently 
come from a trial of breastfeeding promotion.  Children in the experimental group had 
higher mean verbal IQ scores at age 6 compared with the control group,36 but other 
differences in intelligence or in teacher ratings were small and often non-significant.  
It is possible that women who were more intelligent or better educated, and hence had 
more verbally competent children, were more receptive to breast feeding promotion.   
 
The strengths of this study include the detailed milk feeding histories collected during 
infancy, the comprehensive psychological assessment of the children at age four 
years, and the availability of data on a range of potential confounding factors, 
including maternal intelligence and quality of the home environment.    
 
The study also has limitations.  Firstly, compared to women who did not take part, the 
women who agreed to participate in this follow-up study were better educated, of 
higher social class, and a higher proportion had breastfed their child.  Compared to the 
entire SWS birth cohort, women from more disadvantaged socioeconomic groups and 
those who fed their child primarily on formula during infancy are therefore under-
represented in this study.   However, it is unlikely that this will have biased our 
findings unless the relation between type of milk fed and child’s neurocognitive 
function is different in those who did not take part in our study.  Secondly, our 
calculation of total DHA intake in milk is likely to contain inaccuracies: it is 
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dependent on maternal recall of the brands of formula used, and in the absence of data 
on the actual DHA content of each mother's breast milk and on the volume of milk 
drunk, we had to base our calculations on recent estimates of the average DHA 
content of breast milk in the UK and of the amount of milk drunk in the first few 
months of life. This might have affected our ability to detect any relation between 
DHA intake and later performance.  Finally, the number on which our study was 
based was smaller than originally planned, so we may have lacked statistical power to 
detect differences in scores on some of the tests.  A post-hoc power calculation 
showed that our study had >90% power to detect differences in verbal IQ between 
milk feeding groups of the size found here in unadjusted analyses, and >70% power in 
the case of full-scale IQ.   
 
In this study, we found that differences in IQ between children who were breastfed 
and those fed unfortified formula in infancy were largely explained by maternal 
educational attainment and intelligence.   Children fed DHA-enriched formula did 
have higher full-scale and verbal IQ than those fed unfortified formula, despite control 
for a range of potential confounders, but this did not appear to be due to the DHA 
content of these milks.   
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What is already known on this topic 
 
Studies in animals show that lack of the long-chain polyunsaturated fatty acid 
docosahexaenoic acid (DHA) during periods of rapid brain growth may lead to 
impaired neurodevelopment, but trials of the effect of DHA-fortified formula in 
babies have produced conflicting results. 
 
Whether the use of such formulas is associated with longer-term benefits in children’s 
cognitive or neuropsychological performance is unclear. 
 
 
 
What this study adds    
 
Children fed predominantly with DHA-fortified formula in infancy had higher full-
scale and verbal IQ scores at age 4 years than those fed with unfortified formula, but 
these differences were not explained by higher intakes of DHA in infancy. 
 
Differences in children’s intelligence according to type of milk fed in infancy may be 
due more to confounding by maternal or family characteristics than to the amount of 
long-chain polyunsaturated fatty acids they receive in milk 
 16
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Table 1:  Characteristics of the study participants according to milk-
feeding group 
Characteristics Breastmilk 
n=130 
Fortified 
formula  
n=65 
Unfortified 
formula 
n=46 
P 
value  
 Mean (SD) 
or No (%) 
Mean (SD) or 
No (%) 
Mean (SD) 
or No (%) 
 
Mother     
Educated to A level or higher, 
no (%) 
97 (74.6) 35 (53.9) 17 (37.0) <0.001
Social class I or II, no (%) 94 (72.3) 31 (47.7) 20 (43.5) <0.001
On benefits, no (%) 8 (6.2) 11 (16.9) 8 (17.4) 0.027 
Full-scale IQ 111.7 (10.9) 107.0 (9.3) 100.9 (11.0) <0.001
Age at birth, yr 30.8 (3.3) 30.3 (3.5) 29.2 (3.7) 0.007 
HOME cognitive stimulation  9.09 (1.18) 8.97 (1.16) 9.00 (1.07) 0.543 
HOME emotional support  2.19 (0.96) 1.92 (0.91) 2.22 (0.92) 0.733 
Returned to work before 
child’s 1st birthday, no (%) 
78 (60.0) 35 (53.9) 30 (65.2) 0.474 
     
Child     
Female, no (%) 61 (46.9) 33 (50.8) 17 (37.0) 0.341 
First or only child, no (%) 60 (46.2) 39 (60.0) 22 (47.8) 0.178 
Birthweight, kg 3.51 (0.48) 3.37 (0.68) 3.35 (0.47) 0.040 
Gestational age, wks 39.8 (1.66) 39.5 (2.41) 39.7 (1.70) 0.435 
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Table 2: Differences in IQ scores at age 4 between the breastmilk or DHA-
fortified formula groups compared to the unfortified formula group.  Estimates 
are shown unadjusted, adjusted separately for each potential confounder, then 
fully adjusted 
 
  Regression coefficient (95% CI) 
Feeding group  Full scale IQ Verbal IQ Performance IQ 
Breastmilk Unadjusted 5.29 
(1.16, 9.43) 
7.61 
(2.71, 12.5) 
2.25 
(-2.33, 6.84) 
 Adjusted for:    
 Maternal IQ 3.70 
(-0.71, 8.10) 
4.82 
(-0.35, 9.98) 
1.59 
(-3.33, 6.50) 
 Education 2.59 
(-1.72, 6.91) 
3.95 
(-1.12, 9.02) 
0.82 
(-4.05, 5.69) 
 Social class 4.15 
(0.1, 8.30) 
6.41 
(1.47, 11.3) 
1.14 
(-3.47, 5.76) 
 On benefits 4.85 
(0.69, 9.00) 
6.91 
(2.00, 11.8) 
1.82 
(-2.80, 6.43) 
 Age at birth 5.71 
(1.50, 9.91) 
8.32 
(3.35, 13.3) 
2.23 
(-2.44, 6.90) 
 Birthweight 4.85 
(0.71, 8.99) 
7.46 
(2.52, 12.4) 
1.37 
(-3.15, 5.89) 
 All 2.51 
(-1.97, 6.98) 
3.66 
(-1.66, 8.92) 
0.29 
(-4.69, 5.27) 
     
Fortified formula Unadjusted 6.52 
(1.88, 11.1) 
8.57 
(3.07, 14.1) 
3.31 
(-1.84, 8.46) 
 Adjusted for:    
 Maternal IQ 5.63 
(0.92, 10.3) 
7.00 
(1.48, 12.5) 
2.93 
(-2.32, 8.18) 
 Education 5.21 
(0.62, 9.81) 
6.80 
(1.40, 12.2) 
2.61 
(-2.58, 7.81) 
 Social class 6.14 
(1.55, 10.7) 
8.16 
(2.71, 13.6) 
2.93 
(-2.17, 8.03) 
 On benefits 6.51 
(1.87, 11.1) 
8.54 
(3.08, 14.0) 
3.29 
(-1.85, 8.43) 
 Age at birth 6.82 
(2.12, 11.5) 
9.09 
(3.56, 14.6) 
3.29 
(-1.91, 8.49) 
 Birthweight 6.46 
(1.83, 11.1) 
8.55 
(3.04, 14.1) 
3.17 
(-1.87, 8.22) 
 All 5.62 
(0.98, 10.2) 
7.02 
(1.56, 12.4) 
2.99 
(-2.18, 8.16) 
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Table 3:   Differences in other neurocognitive test scores at age 4 between the 
breastmilk or DHA-fortified formula groups compared to the unfortified 
formula group.  Estimates are shown unadjusted, then multivariate-adjusted* 
 
       
Adjustments Feeding 
group 
Visual form 
constancy 
scaled score 
Visual 
attention 
scaled 
score 
Visuomotor 
precision 
scaled 
score 
Sentence 
repetition 
scaled score 
Verbal 
fluency 
scaled 
score 
Unadjusted Breast 
milk 
0.44 
(-0.46, 1.54) 
0.17 
(-0.26, 0.60) 
0.77 
(-0.25, 1.79) 
0.67 
(-0.16, 1.50) 
-0.13 
(-1.08, 0.82) 
 Fortified 
formula 
0.27 
(-0.74, 1.28) 
0.40 
(-0.09, 0.88) 
0.40 
(-0.75, 1.54) 
0.76 
(-0.17, 1.70) 
0.43 
(-0.63, 1.49) 
       
       
Multivariate- 
adjusted* 
Breast 
milk 
0.20 
(-0.82, 1.21) 
0.31 
(-0.18, 0.79) 
1.06 
(-0.07, 2.18) 
-0.19 
(-1.09, 0.71) 
-0.53 
(-1.59, 0.52) 
 Fortified 
formula 
0.21 
(-0.83, 1.25) 
0.45 
(-0.05, 0.95) 
0.62 
(-0.54, 1.78) 
0.34 
(-0.59, 1.28) 
0.25 
(-0.84, 1.34) 
*adjusted for  birth weight, maternal age, IQ, educational qualifications, social class, 
and receipt of benefits .   
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Table 4:  Change in cognitive and neuropsychological test scores at age 4 for a 1-gram increase in estimated DHA intake from milk in 
the first 6 months of life. Estimates are shown unadjusted, then multivariate-adjusted* 
 
 
 Regression coefficient (95% CI) 
Adjustments Full-scale IQ Verbal IQ Performance 
IQ 
Visual form 
constancy 
scaled score 
Visual 
attention 
scaled 
score 
Visuomotor 
precision 
scaled 
score 
Sentence 
repetition 
scaled score 
Verbal 
fluency 
scaled 
score 
       
         
Unadjusted 0.18 
(-0.12, 0.48) 
0.32 
(-0.03, 0.68) 
-0.01 
(-0.34, 0.32) 
0.06 
(-0.01, 0.12) 
0.03 
(-0.01, 0.06) 
0.01 
(-0.06, 0.09) 
0.02 
(-0.04, 0.08) 
-0.01 
(-0.07, 0.06) 
        
Multivariate-
adjusted* 
0.06 
(-0.24, 0.37) 
0.14 
(-0.21, 0.50) 
-0.07 
(-0.41, 0.27) 
0.05 
(-0.02, 0.12) 
0.03 
(-0.01, 0.06) 
0.02 
(-0.06, 0.10) 
-0.01 
(-0.07, 0.05) 
-0.02 
(-0.09, 0.05) 
         
*adjusted for  birth weight, maternal age, IQ, educational qualifications, social class, and receipt of benefits.   
 
 
